DMD
Clinical trials for DMD explained in plain language.
Never miss a new study
Get alerted when new DMD trials appear
Sign up with your email to follow new studies for DMD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill for duchenne MD enters Mid-Stage trial in young boys
Disease control Recruiting nowThis study tests an oral drug called SAT-3247 in 51 boys aged 7 to 10 with Duchenne muscular dystrophy who can still walk. The goal is to find the best dose, check safety, and see if it helps muscle strength. Participants take the drug or a placebo for 12 weeks, and all continue …
Matched conditions: DMD
Phase: PHASE2 • Sponsor: Satellos Bioscience, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug could help boys with duchenne walk and move longer
Disease control Recruiting nowThis study tests a new medicine called DYNE-251 in boys aged 4 to 18 with Duchenne muscular dystrophy (DMD) who can still walk. The goal is to see if it helps them move better and slows muscle damage. Participants will receive either the drug or a placebo every 4 weeks for about …
Matched conditions: DMD
Phase: PHASE3 • Sponsor: Dyne Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Could a common ED drug and cycling help kids with duchenne?
Disease control Recruiting nowThis study is testing whether a drug called tadalafil (often used for erectile dysfunction) combined with a home cycling program can help boys with Duchenne muscular dystrophy. The drug aims to improve blood flow to muscles, which is often poor in DMD, while exercise builds stren…
Matched conditions: DMD
Phase: PHASE2 • Sponsor: University of Florida • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New hope for duchenne: experimental drug targets genetic glitch
Disease control Recruiting nowThis study tests an experimental drug called NS-089/NCNP-02 (Brogidirsen) in 20 boys with Duchenne muscular dystrophy whose genetic mutation can be fixed by skipping exon 44. The drug is given as a weekly IV infusion and aims to help the body produce a working version of the dyst…
Matched conditions: DMD
Phase: PHASE2 • Sponsor: NS Pharma, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
Gene therapy trial hopes to slow duchenne muscular dystrophy in young boys
Disease control Recruiting nowThis early-stage study tests a gene therapy called BBM-D101 in 9 boys aged 4 to 8 with Duchenne muscular dystrophy (DMD). The goal is to see if it is safe and can help produce a missing protein in muscles. Researchers will monitor side effects and measure changes in muscle health…
Matched conditions: DMD
Phase: PHASE1, PHASE2 • Sponsor: Belief BioMed (Beijing) Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Swiss launch major registry to track rare muscle diseases
Knowledge-focused Recruiting nowThis study is a registry that collects health information from people in Switzerland who have neuromuscular disorders like SMA, DMD, BMD, and others. It aims to track symptoms, treatments, and outcomes over time to help researchers and doctors improve care. No new treatments are …
Matched conditions: DMD
Sponsor: University of Bern • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:11 UTC